⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4421530 | 0.72 | — | — | |
| SCHEMBL15899108 | 0.71 | — | — | |
| SCHEMBL6525155 | 0.71 | — | — | |
| Hydrogen Sulfide SCHEMBL11212372 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL9400716 | 0.69 | — | — | |
| SCHEMBL6032976 | 0.69 | — | — | |
| SCHEMBL5698961 | 0.67 | — | — | |
| SCHEMBL5699107 | 0.67 | — | — | |
| SCHEMBL2108714 | 0.67 | — | — | |
| SCHEMBL11027265 | 0.64 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121952-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | Novo Nordisk Health Care AG (CH) | 2009-11-25 | — | — | EP | claimed |
| WO-2008101957-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | NOVO NORDISK HEALTH CARE AG (DK) | 2008-08-28 | — | — | WO | claimed |
| JP-2007518747-A | — | — | 2007-07-12 | — | — | JP | claimed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | claimed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | claimed |
| EP-2324056-A1 | GROWTH HORMONE CONJUGATE WITH INCREASED STABILITY | Novo Nordisk Health Care AG (CH) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010029107-A1 | GROWTH HORMONE CONJUGATE WITH INCREASED STABILITY | NOVO NORDISK HEALTH CARE AG (CH) | 2010-03-18 | — | — | WO | disclosed |
| EP-2121952-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | Novo Nordisk Health Care AG (CH) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008101957-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | NOVO NORDISK HEALTH CARE AG (DK) | 2008-08-28 | — | — | WO | disclosed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | disclosed |